Clinical Trials Sponsored by Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud

Total 50 results

Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral

Amyotrophic Lateral Sclerosis

Spain
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

Intraarterial Infusion of Autologous Bone Marrow in Diabetic Patients With Chronic Ischemia of Lower Limbs (CLI) no Revascularization

Diabetic Foot | Critical Limb Ischemia (CLI)

Spain
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Non-diabetic Patients With Critical Limb Ischemia (CLI).

Critical Limb Ischemia (CLI)

Spain
Andalusian Initiative for Advanced Therapies -...
Andalusian Initiative for Advanced Therapies

Completed

Clinical Trial With MSC for Graft Versus Host Disease Treatment

Acute Graft Versus Host Disease

Spain
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple Sclerosis

Multiple Sclerosis

Spain
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Terminated

Clinical Trial I/II Opened, Randomized and Controlled for the Study of the Use of Stem Cells Therapy in Insulinized Diabetic Patients Type 2 With Critical Ischemia in Lower Limbs (CLI): Study of the Needs of Insulin

Critical Limb Ischemia (CLI)

Spain
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

Application of Cell Regeneration Therapy With Mesenchymal Stem Cells From Adipose Tissue in Critical Chronic Ischemic Syndrome of Lower Limbs (CLI) in Nondiabetic Patients.

Critical Limb Ischemia

Spain
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease. (CMM/EICH/2008)

Immune System Diseases | Graft Versus Host Disease | Chronic and Expanded Graft Versus Host Disease

Spain
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

Cell Infusion Intraportal Autologous Bone Marrow Mononuclear as Enhancer of Liver Regeneration

Liver Transplant Rejection

Spain
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized.

Coronary Atherosclerosis and Other Heart Disease

Spain
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment

Severe Trophic Corneal Ulcers Refractory to Conventional Treatment | Sequelae of Previous Trophic Corneal Ulcers

Spain
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Terminated

Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure.

Idiopathic Dilated Cardiomyopathy

Spain
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response

Discordant Immunological Response in HIV Infected Subjects

Spain
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Withdrawn

Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological Malignancies

Transplant-Related Hematologic Malignancy

Spain
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence

Faecal Incontinence

Spain
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients

Diabetes | Critical Limb Ischemia (CLI)

Spain
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

Intracoronary Infusion of Bone Marrow Mononuclear Cells in Patients With Previous Myocardial Infarction.

Chronic Myocardial Ischemia

Spain
Andalusian Initiative for Advanced Therapies -...

Unknown

Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome

Acute Coronary Syndromes

Spain
Andalusian Initiative for Advanced Therapies -...

Unknown

Impact of Eslicarbazepine Acetate on Lipid Metabolism and Cardiovascular Risk Factors

Epilepsy

Spain
Fundación Pública Andaluza Progreso y Salud
Iniciativa Andaluza en Terapias Avanzadas

Completed

Intracoronary Infusion of Autologous Bone Marrow Cells for Treatment of Idiopathic Dilated Cardiomyopathy

Dilated Cardiomyopathy

Spain
Fundación Pública Andaluza Progreso y Salud

Completed

Efficacy and Safety of Topical Application of Tranexamic Acid for Saving Blood Losses in Patients Subjected to Prosthetic Knee Surgery (TRA)

Osteoarthritis, Knee

Spain
Fundación Pública Andaluza Progreso y Salud

Unknown

Antiplatelet Therapy in Acute Coronary Syndrome(ACS). Safety and Efficacy of Switching Antiplatelet

Acute Coronary Syndrome

Spain
Fundación Pública Andaluza Progreso y Salud

Completed

Errors in the Use of Turbuhaler and Spiromax Devices Patients With Asthma

Asthma

Spain
Fundación Pública Andaluza Progreso y Salud

Unknown

Register of Treatment of Unprotected Left Main Coronary Artery Stenosis in Andalucía (RETRATO)

Unprotected Left Main Coronary Artery Stenosis

Spain
Fundación Pública Andaluza Progreso y Salud

Completed

Register of Telaprevir and Boceprevir in Routine Clinical Practice

Hepatitis C

Spain
Fundación Pública Andaluza Progreso y Salud

Unknown

Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System

Carcinoma, Non-Small-Cell Lung

Spain
Fundación Pública Andaluza Progreso y Salud

Completed

Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Balloon Catheter vs PTA Balloon (FISBAL)

Arteriovenous Fistula Renal Dialysis Devices Obstruction

Spain
Fundación Pública Andaluza Progreso y Salud

Unknown

Effectiveness of Low Energy Laser Treatment in Oral Mucositis Induced by Chemotherapy and Radiotherapy in Head and Neck Cancer

Oral Mucositis

Spain
Fundación Pública Andaluza Progreso y Salud

Completed

Study of the Impact of the Minimum Inhibitory Concentration and Susceptible Cut-off Points (CLSI, EUCAST, and Pharmacokinetics/Pharmacodynamics)in Prognosis of Bacteremia by Enterobacteriaceae (BACTERIEMIA)

Bacteremia by Enterobacteriaceae

Spain
Fundación Pública Andaluza Progreso y Salud

Terminated

Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.

Staphylococcus

Spain
Fundación Pública Andaluza Progreso y Salud

Completed

Effects of Analgesics in Cesarean Section Elective (CES)

Anesthesia; Functional

Spain
Fundación Pública Andaluza Progreso y Salud

Completed

Clinical Trial to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis (COX)

Coxarthrosis

Spain
Fundación Pública Andaluza Progreso y Salud

Completed

Insulin in Total Parenteral Nutrition (INSUPAR)

Diabetes Mellitus

Spain
Fundación Pública Andaluza Progreso y Salud

Completed

Clinical Efficacy of OneTouch® Verio™IQ Meter (ECOVIQ)

Diabetes Mellitus

Spain
Fundación Pública Andaluza Progreso y Salud

Completed

Etanercept Survival in Elderly Population

Psoriasis

Spain
Fundación Pública Andaluza Progreso y Salud

Completed

Roflumilast Safety Administered Once a Day on Alternate Days for Two Weeks Compared to the Usual Dosage Once Daily (ROFLU2011)

Chronic Obstructive Pulmonary Disease (COPD)

Spain
Fundación Pública Andaluza Progreso y Salud

Unknown

Multicenter Intervention Program to Optimize the Clinical Management of Community-acquired Pneumonia in Hospitals

Community Acquired Pneumonia

Spain
Fundación Pública Andaluza Progreso y Salud

Completed

Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs

Chronic Hepatitis B Treated With Nucleoside/Nucleotide Analogues

Spain
Fundación Pública Andaluza Progreso y Salud

Completed

Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in Improving the Clinical Management and Review of the Clinical and Molecular Epidemiology

Staphylococcus Aureus Bacteremia

Spain
Andalusian Initiative for Advanced Therapies -...
Carlos III Health Institute

Completed

Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis

Nervous System Diseases | Immune System Diseases | Demyelinating Autoimmune Diseases, CNS | Autoimmune Diseases of the Nervous System | Demyelinating Diseases | Autoimmune Diseases

Spain
Universidad de Granada
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza... and other collaborators

Unknown

@ctiveHip Tele-rehabilitation System (@ctiveHip)

Hip Fractures

Spain
Fundación Pública Andaluza Progreso y Salud
Gilead Sciences

Completed

Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort." (hEPAtic)

Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects

Spain
Fundación Pública Andaluza Progreso y Salud
Instituto de Salud Carlos III

Unknown

Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis (NONSTOP)

Psychosis Nos/Other

Spain
Fundación Pública Andaluza Progreso y Salud
Ministry of Health, Spain

Terminated

Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy (RITULUP)

Lupus Nephritis

Spain
Fundación Pública Andaluza Progreso y Salud
Telefónica S.A.; Agency of Social Services and Dependency of Andalusia; Salud...

Unknown

Integral Clinical Plan Shared With or Without Telemonitoring of Constants in Patient With Chronic Diseases (ATLAN_TIC01)

Chronic Lung Disease | Chronic Heart Disease

Spain
Fundación Pública Andaluza Progreso y Salud
Hospital Universitario Reina Sofia de Cordoba

Completed

Predilation of Side Branch During Percutaneous Treatment of Bifurcation Lesions With Provisional T Stenting

Coronary Angiography

Spain
Fundación Pública Andaluza Progreso y Salud
Spanish Network for Research in Infectious Diseases

Completed

Clinical Trial Evaluating Efficacy and Safety of One Dose Versus Two Doses of Influenza Vaccination (TraNsgripe)

Infection in Solid Organ Transplant Recipients

Spain
Fundación Pública Andaluza Progreso y Salud
Karolinska Institutet; Eli Lilly and Company; Medical University of Vienna; Sanofi and other collaborators

Completed

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort (PRECISESADSI)

Systemic Autoimmune Diseases

France, Belgium, Germany, Italy, Spain, Switzerland
Fundación Pública Andaluza Progreso y Salud
Karolinska Institutet; Eli Lilly and Company; Medical University of Vienna; Sanofi and other collaborators

Completed

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: (PRECISESADS)

Systemic Autoimmune Diseases

France, Germany, Austria, Portugal, Hungary, Belgium, Italy, Spain, Switzerland
Fundación Pública Andaluza Progreso y Salud
Karolinska Institutet; Eli Lilly and Company; Medical University of Vienna; Sanofi and other collaborators

Completed

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control (PRECISESADST)

Healthy Subjects

France, Austria, Germany, Portugal, Hungary, Belgium, Italy, Spain, Switzerland

Clinical Trials Sponsored by Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations